Dr Marc Henninger is Market Access Manager of ELANCO, animal health division of Lilly
Marc Henninger graduated as “Docteur Vétérinaire” (DVM) at the Veterinary College in Nantes 1994 . He has a Master degree in Business (IAE-IGR Rennes).
After working from 1995 to 2010 in several positions in genetic and Feed companies, mainly linked to swine health, he joined in 2010 ELANCO France as technical consultant to support Swine vaccines. Since 2014, he is responsible for Market Access in France and most recently took over the responsibility of Market Access in North West Africa and some Middle East countries. He represent ELANCO in several working groups of SIMV, the French association of animal health industry representing manufacturers of medicines and diagnostics for animals. He is also president of RESEDA, a French association gathering various stakeholders involved in agriculture, animal and plants. In his current job at ELANCO, Marc Henninger is focusing on responsible use of antibiotics and alternatives and a keen supporter of the One Health concept.